Showing results (1971-1980 of 2,134) with videos related to

Sort By:
Pageof 214
JACC. Cardiovascular Interventions|January 15, 2025
Clinical Characteristics and Outcomes of Patients Undergoing 3 Aortic Valve Interventions: The THIRD Multicenter RegistryGiuseppe Tarantini, Gilbert H L Tang, Thomas Pilgrim, et al.
European Journal of Heart Failure|December 12, 2024
Management of acute decompensated valvular heart diseaseEnzo Lüsebrink, Hugo Lanz, Antonia Kellnar, et al.
Physical Review Letters|October 21, 2022
Quenching of Single-Particle Strength in A=15 NucleiB P Kay, T L Tang, I A Tolstukhin, et al.
Heart Rhythm|January 22, 2013
Failure rate of the Riata lead under advisory: a report from the CHRS Device CommitteeRatika Parkash, Derek Exner, Jean Champagne, et al.
JACC. Cardiovascular Interventions|June 22, 2026
BenchTop Validation of UNICORN Leaflet Modification Technique in Redo-Transcatheter Aortic Valve ReplacementSimon Cheung-Chi Lam, Ho-On Alston Conrad Chiu, Kwong-Yue Eric Chan, et al.
JACC. Cardiovascular Interventions|June 22, 2026
Leaflet Modification Technique With UNICORN in Failed Aortic Bioprosthesis: Procedural Step-by-Step, Best Practice, and TroubleshootingKwong-Yue Eric Chan, Ka-Chun Un, Ho-On Alston Conrad Chiu, et al.
American Journal of Human Genetics|March 10, 2009
Genome-wide association and replication studies identified TRHR as an important gene for lean body massXiao-Gang Liu, Li-Jun Tan, Shu-Feng Lei, et al.
JMIR Research Protocols|February 20, 2014
Development and content validation of the information assessment method for patients and consumersPierre Pluye, Vera Granikov, Gillian Bartlett, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 16, 2021
Outcomes of transcatheter mitral valve repair for secondary mitral regurgitation by severity of left ventricular dysfunctionStamatios Lerakis, Annapoorna S Kini, Federico M Asch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2020
Efficacy of utidelone plus capecitabine versus capecitabine for heavily pretreated, anthracycline- and taxane-refractory metastatic breast cancer: final analysis of overall survival in a phase III randomised controlled trialB Xu, T Sun, Q Zhang, et al.
Pageof 214